| A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease |
20 |
| The Case for Proteomics and Phospho-Proteomics in Personalized Cancer Medicine |
20 |
| Site-to-Site Reproducibility and Spatial Resolution in MALDI-MSI of Peptides from Formalin-Fixed Paraffin-Embedded Samples |
12 |
| Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease |
12 |
| Co-expression Network Analysis Identified Key Proteins in Association With Hepatic Metastatic Colorectal Cancer |
11 |
| Identification of Proteomic Markers in Head and Neck Cancer Using MALDI-MS Imaging, LC-MS/MS, and Immunohistochemistry |
10 |
| MALDI-Imaging for Classification of Epithelial Ovarian Cancer Histotypes from a Tissue Microarray Using Machine Learning Methods |
10 |
| The Impact of the Glomerular Filtration Rate on the Human Plasma Proteome |
9 |
| Eccrine Sweat as a Biofluid for Profiling Immune Biomarkers |
9 |
| A Comparative Proteomics Analysis of Five Body Fluids: Plasma, Urine, Cerebrospinal Fluid, Amniotic Fluid, and Saliva |
9 |
| High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy |
8 |
| Clinical Proteomics for Precision Medicine: The Bladder Cancer Case |
8 |
| MALDI Imaging-Guided Microproteomic Analyses of Heterogeneous Breast Tumors-A Pilot Study |
8 |
| Implementation of Proteomics in Clinical Trials |
7 |
| One-Pot Sample Processing Method for Proteome-Wide Analysis of Microbial Cells and Spores |
7 |
| Membrane Proteome of Invasive Retinoblastoma: Differential Proteins and Biomarkers |
7 |
| Increases in Tumor N-Glycan Polylactosamines Associated with Advanced HER2-Positive and Triple-Negative Breast Cancer Tissues |
7 |
| Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial Information |
6 |
| Extracellular Matrix Imaging of Breast Tissue Pathologies by MALDI-Imaging Mass Spectrometry |
6 |
| Variability Assessment of 90 Salivary Proteins in Intraday and Interday Samples from Healthy Donors by Multiple Reaction Monitoring-Mass Spectrometry |
6 |
| Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide Handling |
6 |
| Peptidome Analysis Reveals Novel Serum Biomarkers for Children with Autism Spectrum Disorder in China |
6 |
| Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation |
6 |
| Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer |
6 |
| Urinary Proteomics and Precision Medicine for Chronic Kidney Disease: Current Status and Future Perspectives |
6 |
| Multiplexed LC-ESI-MRM-MS-based Assay for Identification of Coronary Artery Disease Biomarkers in Human Plasma |
6 |
| iTRAQ-Based Proteomic Analysis Reveals Protein Profile in Plasma from Children with Autism |
6 |
| Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine |
6 |
| Proteomic Analysis of the Initial Oral Pellicle in Caries-Active and Caries-Free Individuals |
6 |
| Plasma Proteomics Analysis Reveals Dysregulation of Complement Proteins and Inflammation in Acquired Obesity-A Study on Rare BMI-Discordant Monozygotic Twin Pairs |
5 |
| Quantitative Urinary Proteome Reveals Potential Biomarkers for Ureteropelvic Junction Obstruction |
5 |
| The Proteomic Profile of Keratinocytes and Lymphocytes in Psoriatic Patients |
5 |
| Mass spectrometry-based protein analysis to unravel the tissue pathophysiology in Duchenne muscular dystrophy |
5 |
| Imaging Mass Spectrometry for Characterization of Atrial Fibrillation Subtypes |
5 |
| Lectin Microarray Combined with Mass Spectrometry Identifies Haptoglobin-Related Protein (HPR) as a Potential Serologic Biomarker for Separating Nonbacterial Pneumonia from Bacterial Pneumonia in Childhood |
5 |
| A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer |
5 |
| Maternal Apolipoprotein B100 Serum Levels are Diminished in Pregnancies with Intrauterine Growth Restriction and Differentiate from Controls |
5 |
| Discerning the Primary Carcinoma in Malignant Peritoneal and Pleural Effusions Using Imaging Mass Spectrometry-A Feasibility Study |
5 |
| Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging |
5 |
| Proteomic Landscape of Cholangiocarcinomas Reveals Three Different Subgroups According to Their Localization and the Aspect of Non-Tumor Liver |
5 |
| Identification of Protein Abundance Changes in Hepatocellular Carcinoma Tissues Using PCT-SWATH |
5 |
| ExSTA: External Standard Addition Method for Accurate High-Throughput Quantitation in Targeted Proteomics Experiments |
4 |
| Intersection of Proteomics and Genomics to Solve the Unsolved in Rare Disorders such as Neurodegenerative and Neuromuscular Diseases |
4 |
| A Proteogenomic Analysis of Haptoglobin in Malaria |
4 |
| Identification of Host-Response in Cerebral Malaria Patients Using Quantitative Proteomic Analysis |
4 |
| The differential plasma proteome of obese and overweight individuals undergoing a nutritional weight loss and maintenance intervention |
4 |
| Comparative Proteomics Analysis of Serum Proteins in Gestational Diabetes during Early and Middle Stages of Pregnancy |
4 |
| In-Depth Proteomic Analysis of Human Bronchoalveolar Lavage Fluid toward the Biomarker Discovery for Lung Cancers |
4 |
| The Platelet Releasate is Altered in Human Pregnancy |
4 |
| Urinary Glycopeptide Analysis for the Investigation of Novel Biomarkers |
4 |
